Literature DB >> 20144044

Etiology of illness in patients with severe sepsis admitted to the hospital from the emergency department.

Alan C Heffner1, James M Horton, Michael R Marchick, Alan E Jones.   

Abstract

BACKGROUND: Patients identified with sepsis in the emergency department often are treated on the basis of the presumption of infection; however, various noninfectious conditions that require specific treatments have clinical presentations very similar to that of sepsis. Our aim was to describe the etiology of illness in patients identified and treated for severe sepsis in the emergency department.
METHODS: We conducted a prospective observational study of patients treated with goal-directed resuscitation for severe sepsis in the emergency department. Inclusion criteria were suspected infection, 2 or more criteria for systemic inflammation, and evidence of hypoperfusion. Exclusion criteria were age of <18 years and the need for immediate surgery. Clinical data on eligible patients were prospectively collected for 2 years. Blinded observers used a priori definitions to determine the final cause of hospitalization.
RESULTS: In total, 211 patients were enrolled; 95 (45%) had positive culture results, and 116 (55%) had negative culture results. The overall mortality rate was 19%. Patients with positive culture results were more likely to have indwelling vascular lines (P = .03), be residents of nursing homes (P = .04), and have a shorter time to administration of antibiotics in the emergency department (83 vs 97 min; P = .03). Of patients with negative culture results, 44% had clinical infections, 8% had atypical infections, 32% had noninfectious mimics, and 16% had an illness of indeterminate etiology.
CONCLUSION: In this study, we found that >50% of patients identified and treated for severe sepsis in the emergency department had negative culture results. Of patients identified with a sepsis syndrome at presentation, 18% had a noninfectious diagnosis that mimicked sepsis, and the clinical characteristics of these patients were similar to those of patients with culture-positive sepsis.

Entities:  

Mesh:

Year:  2010        PMID: 20144044      PMCID: PMC2921279          DOI: 10.1086/650580

Source DB:  PubMed          Journal:  Clin Infect Dis        ISSN: 1058-4838            Impact factor:   9.079


  14 in total

1.  Epidemiology of severe sepsis in the United States: analysis of incidence, outcome, and associated costs of care.

Authors:  D C Angus; W T Linde-Zwirble; J Lidicker; G Clermont; J Carcillo; M R Pinsky
Journal:  Crit Care Med       Date:  2001-07       Impact factor: 7.598

2.  Before-after study of a standardized hospital order set for the management of septic shock.

Authors:  Scott T Micek; Nareg Roubinian; Tim Heuring; Meghan Bode; Jennifer Williams; Courtney Harrison; Theresa Murphy; Donna Prentice; Brent E Ruoff; Marin H Kollef
Journal:  Crit Care Med       Date:  2006-11       Impact factor: 7.598

3.  Prospective external validation of the clinical effectiveness of an emergency department-based early goal-directed therapy protocol for severe sepsis and septic shock.

Authors:  Alan E Jones; Anne Focht; James M Horton; Jeffrey A Kline
Journal:  Chest       Date:  2007-06-15       Impact factor: 9.410

4.  Dear SIRS, I'm sorry to say that I don't like you...

Authors:  J L Vincent
Journal:  Crit Care Med       Date:  1997-02       Impact factor: 7.598

Review 5.  2001 SCCM/ESICM/ACCP/ATS/SIS International Sepsis Definitions Conference.

Authors:  Mitchell M Levy; Mitchell P Fink; John C Marshall; Edward Abraham; Derek Angus; Deborah Cook; Jonathan Cohen; Steven M Opal; Jean-Louis Vincent; Graham Ramsay
Journal:  Crit Care Med       Date:  2003-04       Impact factor: 7.598

Review 6.  The international sepsis forum consensus conference on definitions of infection in the intensive care unit.

Authors:  Thierry Calandra; Jonathan Cohen
Journal:  Crit Care Med       Date:  2005-07       Impact factor: 7.598

7.  Influence of systemic inflammatory response syndrome and sepsis on outcome of critically ill infected patients.

Authors:  Corinne Alberti; Christian Brun-Buisson; Sergey V Goodman; Daniela Guidici; John Granton; Rui Moreno; Mark Smithies; Oliver Thomas; Antonio Artigas; Jean Roger Le Gall
Journal:  Am J Respir Crit Care Med       Date:  2003-04-17       Impact factor: 21.405

8.  Implementation and outcomes of the Multiple Urgent Sepsis Therapies (MUST) protocol.

Authors:  Nathan I Shapiro; Michael D Howell; Daniel Talmor; Dermot Lahey; Long Ngo; Jon Buras; Richard E Wolfe; J Woodrow Weiss; Alan Lisbon
Journal:  Crit Care Med       Date:  2006-04       Impact factor: 7.598

9.  Translating research to clinical practice: a 1-year experience with implementing early goal-directed therapy for septic shock in the emergency department.

Authors:  Stephen Trzeciak; R Phillip Dellinger; Nicole L Abate; Robert M Cowan; Mary Stauss; J Hope Kilgannon; Sergio Zanotti; Joseph E Parrillo
Journal:  Chest       Date:  2006-02       Impact factor: 9.410

10.  Rapid increase in hospitalization and mortality rates for severe sepsis in the United States: a trend analysis from 1993 to 2003.

Authors:  Viktor Y Dombrovskiy; Andrew A Martin; Jagadeeshan Sunderram; Harold L Paz
Journal:  Crit Care Med       Date:  2007-05       Impact factor: 7.598

View more
  40 in total

1.  The potential for PCR based testing to improve diagnosis and treatment of sepsis.

Authors:  Ngan Lyle; John Boyd
Journal:  Curr Infect Dis Rep       Date:  2013-10       Impact factor: 3.725

2.  Circulating biomarkers may be unable to detect infection at the early phase of sepsis in ICU patients: the CAPTAIN prospective multicenter cohort study.

Authors:  Marianna Parlato; François Philippart; Alexandra Rouquette; Virginie Moucadel; Virginie Puchois; Sophie Blein; Jean-Pierre Bedos; Jean-Luc Diehl; Olfa Hamzaoui; Djillali Annane; Didier Journois; Myriam Ben Boutieb; Laurent Estève; Catherine Fitting; Jean-Marc Treluyer; Alexandre Pachot; Minou Adib-Conquy; Jean-Marc Cavaillon; Benoît Misset
Journal:  Intensive Care Med       Date:  2018-06-30       Impact factor: 17.440

3.  Muddy clinical waters: a missed pulmonary embolus.

Authors:  Nathaniel Lee; Simon Rupert Bax
Journal:  BMJ Case Rep       Date:  2014-03-12

4.  Association between timing of antibiotic administration and mortality from septic shock in patients treated with a quantitative resuscitation protocol.

Authors:  Michael A Puskarich; Stephen Trzeciak; Nathan I Shapiro; Ryan C Arnold; James M Horton; Jonathan R Studnek; Jeffrey A Kline; Alan E Jones
Journal:  Crit Care Med       Date:  2011-09       Impact factor: 7.598

5.  Discriminative value of inflammatory biomarkers for suspected sepsis.

Authors:  Ephraim L Tsalik; L Brett Jaggers; Seth W Glickman; Raymond J Langley; Jennifer C van Velkinburgh; Lawrence P Park; Vance G Fowler; Charles B Cairns; Stephen F Kingsmore; Christopher W Woods
Journal:  J Emerg Med       Date:  2011-11-06       Impact factor: 1.484

Review 6.  Sepsis outside intensive care unit: the other side of the coin.

Authors:  F Mearelli; D Orso; N Fiotti; N Altamura; A Breglia; M De Nardo; I Paoli; M Zanetti; C Casarsa; G Biolo
Journal:  Infection       Date:  2014-08-11       Impact factor: 3.553

7.  Infectious Disease Hospitalizations: United States, 2001 to 2014.

Authors:  Jordan L Kennedy; Dana L Haberling; Chaorui C Huang; Fernanda C Lessa; David E Lucero; Demetre C Daskalakis; Neil M Vora
Journal:  Chest       Date:  2019-04-29       Impact factor: 9.410

8.  The authors reply.

Authors:  Sarah A Sterling; Michael A Puskarich; Alan E Jones
Journal:  Crit Care Med       Date:  2016-04       Impact factor: 7.598

9.  A Comparative Study to Assess the Determinants and Outcomes of Sepsis Treated in Medical Wards and ICU in an Indian Teaching Hospital.

Authors:  Prasanta Kumar Bhattacharya; Debdutta Gautom; Neena Nath; Hiranya Saikia
Journal:  J Clin Diagn Res       Date:  2016-06-01

10.  Considerations for Empiric Antimicrobial Therapy in Sepsis and Septic Shock in an Era of Antimicrobial Resistance.

Authors:  Jeffrey R Strich; Emily L Heil; Henry Masur
Journal:  J Infect Dis       Date:  2020-07-21       Impact factor: 5.226

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.